In focus · trending topic

orphan drug

111 stories · following the connections

FDA Recognizes Orphan Drug Exclusivity for Adamas’ GOCOVRI™

By Nasdaq OMXOct 25, 2017, 4:31 PM UTC

Actinium Pharmaceuticals Announces Activation of Fifteenth Clinical Trial Site in the Phase 3 SIERRA Trial for Iomab-B

By Nasdaq OMXOct 25, 2017, 11:30 AM UTC

Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®

By Nasdaq OMXOct 20, 2017, 11:30 AM UTC

Actinium Pharmaceuticals to Present at BIO Investor Forum

By Nasdaq OMXOct 16, 2017, 11:30 AM UTC

Zynerba Pharmaceuticals Announces Positive Top Line Results in ZYN002 Open Label Phase 2 FAB-C Study in Children with Fragile X Syndrome

By Nasdaq OMXSep 28, 2017, 10:30 AM UTC

Actinium Pharmaceuticals Highlights Presence at the Society of Hematologic Oncology 2017 Annual Meeting

By Nasdaq OMXSep 13, 2017, 11:30 AM UTC

Innovate Biopharma’s Pediatric Ulcerative Colitis Drug Granted FDA Orphan Designation

By Nasdaq OMXSep 6, 2017, 9:06 PM UTC

Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017

By Nasdaq OMXAug 23, 2017, 1:05 PM UTC